Some may be conducting research studies known as clinical trials, which test new medications and treatments that are being developed
"In the SURPASS-1 results, tirzepatide led to significant improvements across all primary and key secondary endpoints with clinically meaningful A1C reductions and robust weight loss among study participants, who had a relatively short duration of type 2 diabetes." Tirzepatide is a novel investigational once-weekly dual glucose-dependent insulinotropic polypeptide (GIP) and GLP-1 receptor agonist that integrates the actions of the GIP and GLP-1 incretins into a single molecule, representing a new class of medicines being studied for the treatment of type 2 diabetes
2025 Jul 24
Use a sharps disposal bin provided by Batley Pharmacy
Low vitamin D levels, smoking, obesity, stress, gut microbiota, infections, immunization, heavy metals, and pesticide exposure have been considered risk factors for MS development (Cannon and Greenamyre, 2011